Редактирование: Transhumanist FAQ Version 3 (раздел)

===Biotechnology, genetic engineering, stem cells, and cloning: What are they and what are they good for?===

Biotechnology is the application of techniques and methods based on the biological sciences. It encompasses such diverse enterprises as brewing, manufacture of human insulin, interferon, and human growth hormone, medical diagnostics, cell cloning and reproductive cloning, the genetic modification of crops, bioconversion of organic waste and the use of genetically altered bacteria in the cleanup of oil spills, stem cell research and much more. Genetic engineering is the area of biotechnology concerned with the directed alteration of genetic material.

Biotechnology already has countless applications in industry, agriculture, and medicine. It is a hotbed of research. The completion of the human genome project – a “rough draft” of the entire human genome was published in the year 2000 – was a scientific milestone by anyone’s standards. Research is now shifting to decoding the functions and interactions of all these different genes and to developing applications based on this information.

The potential medical benefits are too many to list; researchers are working on every common disease, with varying degrees of success. Progress takes place not only in the development of drugs and diagnostics but also in the creation of better tools and research methodologies, which in turn accelerates progress. When considering what developments are likely over the long term, such improvements in the research process itself must be factored in. The human genome project was completed ahead of schedule, largely because the initial predictions underestimated the degree to which instrumentation technology would improve during the course of the project. At the same time, one needs to guard against the tendency to hype every latest advance. (Remember all those breakthrough cancer cures that we never heard of again?) Moreover, even in cases where the early promise is borne out, it usually takes ten years to get from proof-of-concept to successful commercialization.

Genetic therapies are of two sorts: somatic and germ-line. In somatic gene therapy, a virus is typically used as a vector to insert genetic material into the cells of the recipient’s body. The effects of such interventions do not carry over into the next generation. Germ-line genetic therapy is performed on sperm or egg cells, or on the early zygote, and can be inheritable. (Embryo screening, in which embryos are tested for genetic defects or other traits and then selectively implanted, can also count as a kind of germ-line intervention.) Human gene therapy, except for some forms of embryo screening, is still experimental. Nonetheless, it holds promise for the prevention and treatment of many diseases, as well as for uses in enhancement medicine. The potential scope of genetic medicine is vast: virtually all disease and all human traits – intelligence, extroversion, conscientiousness, physical appearance, etc. – involve genetic predispositions. Single-gene disorders, such as cystic fibrosis, sickle cell anemia, and Huntington’s disease are likely to be among the first targets for genetic intervention. Polygenic traits and disorders, ones in which more than one gene is implicated, may follow later (although even polygenic conditions can sometimes be influenced in a beneficial direction by targeting a single gene).

Stem cell research, another scientific frontier, offers great hopes for regenerative medicine. Stem cells are undifferentiated (unspecialized) cells that can renew themselves and give rise to one or more specialized cell types with specific functions in the body. By growing such cells in culture, or steering their activity in the body, it will be possible to grow replacement tissues for the treatment of degenerative disorders, including heart disease, Parkinson’s, Alzheimer’s, diabetes, and many others. It may also be possible to grow entire organs from stem cells for use in transplantation. Embryonic stem cells seem to be especially versatile and useful, but research is also ongoing into adult stem cells and the “reprogramming” of ordinary cells so that they can be turned back into stem cells with pluripotent capabilities.

The term “human cloning” covers both therapeutic and reproductive uses. In therapeutic cloning, a preimplantation embryo (also known as a “blastocyst” – a hollow ball consisting of 30-150 undifferentiated cells) is created via cloning, from which embryonic stem cells could be extracted and used for therapy. Because these cloned stem cells are genetically identical to the patient, the tissues or organs they would produce could be implanted without eliciting an immune response from the patient’s body, thereby overcoming a major hurdle in transplant medicine. Reproductive cloning, by contrast, would mean the birth of a child who is genetically identical to the cloned parent: in effect, a younger identical twin.

Everybody recognizes the benefit to ailing patients and their families that come from curing specific diseases. Transhumanists emphasize that, in order to seriously prolong the healthy life span, we also need to develop ways to slow aging or to replace senescent cells and tissues. Gene therapy, stem cell research, therapeutic cloning, and other areas of medicine that have the potential to deliver these benefits deserve a high priority in the allocation of research monies.

Biotechnology can be seen as a special case of the more general capabilities that nanotechnology will eventually provide [see “What is molecular nanotechnology?”].